Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 12443806.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
STUDY AND METHODS: A double-blind placebo-controlled study randomized 108 patients to investigate the effect of sucralfate on gastrointestinal side effects of pelvic radiation. Overall, pelvic radiation with the administered doses and fields and performed according to nowadays technical standards, was well tolerated. Comparison of the mean scores and the peak reactions for radiotherapy discomfort, diarrhoea and number of stools per day in the 80 evaluable patients showed no statistically significant difference between sucralfate and placebo. Based on these results, the use of sucralfate can not be recommended as standard practice.
Medical subject headings
- Fecal Incontinence
- Pelvic Neoplasms
- Radiotherapy, Conformal
- Sucralfate